Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate
2005-07-05
2005-07-05
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
C424S229100, C424S204100, C435S320100, C435S069100
Reexamination Certificate
active
06913751
ABSTRACT:
The present invention provides a novel avian herpesvirus (NAHV) vector and recombinant vaccines made therefrom that are useful to immunize avian species against Marek's disease, infectious laryngotracheitis and Newcastle disease. Methods of immunizing an avian species against Marek's disease, infectious laryngotracheitis and Newcastle disease are also provided.
REFERENCES:
patent: 5138033 (1992-08-01), Velicer et al.
patent: 5187087 (1993-02-01), Sondermeijer et al.
patent: 5231023 (1993-07-01), Morgan
patent: 5252716 (1993-10-01), Velicer et al.
patent: 5283191 (1994-02-01), Morgan et al.
patent: 5470734 (1995-11-01), Sondermeijer et al.
patent: 5506128 (1996-04-01), Cochran et al.
patent: 5686287 (1997-11-01), Baxendale
patent: 5690939 (1997-11-01), Morgan et al.
patent: 5763269 (1998-06-01), Cochran et al.
patent: 5830745 (1998-11-01), Hock et al.
patent: 5834305 (1998-11-01), Cochran et al.
patent: 5866697 (1999-02-01), Velicer et al.
patent: 5928648 (1999-07-01), Cochran
patent: 5961982 (1999-10-01), Cochran
patent: 5965138 (1999-10-01), Cochran et al.
patent: 5976787 (1999-11-01), Velicer et al.
patent: 6051404 (2000-04-01), Morgan et al.
patent: 6087127 (2000-07-01), Velicer et al.
patent: 6121043 (2000-09-01), Cochran et al.
patent: 6153199 (2000-11-01), Audonnet et al.
patent: 6183753 (2001-02-01), Cochran et al.
patent: 0 486 106 (1992-05-01), None
patent: 0 473 210 (1994-04-01), None
patent: 0 431 668 (1995-02-01), None
patent: 0 423 869 (1995-07-01), None
patent: 0 513 921 (1995-08-01), None
patent: WO 87/04463 (1987-07-01), None
patent: WO 92/03547 (1992-03-01), None
patent: WO 00/61736 (2000-10-01), None
patent: WO 02/36617 (2002-05-01), None
Kingham et al. Journal of General Virology, May 2001, vol. 82, 1123-1135.
Afonso, C.L. et al., 2001, The genome of turkey herpesvirus,J. Virol., 75(2):971-978.
Afonso, C.L. et al., 2001, Genbank accession No. AF291866.
Brunovskis, P. et al., 1995, The Marek's disease virus (MDV) unique short region: Alphaherpesvirus homologus, fowlpox virus-homologus, and MDV-specific genes,Virol., 206:324-338.
Brunovskis, P. et al., 1995, Genbank accession No. L22174.
Buckmaster, A.E. et al., 1998, Gene sequencing and mapping data from Marek's disease virus and herpesvirus of turkeys: Implications for herpesvirus classification,J. Gen. Virol., 69:2033-2042.
Cantello, J.L. et al., 1991, Isolation of a Marek's disease virus (MDV) recombinant containing thelacZgene ofEscherichia colistably inserted within the (MDV) US2 gene,J. Virol., 65(3):1584-1588.
Cochran, M.D. and Macdonald, R.D., 1999, Genbank accession No. AR068186.
Cronenberg, A.M. et al., 1999, Vaccination of broilers with HVT expressing anEimeria acervulinaantigen improves performance after challenge withEimeria, Acta Virologica, 43:192-197.
Darteil, R. et al., 1995, Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens,Virol., 211:481-490.
Gubler, V. et al., 1983, A simple and very efficient method for generating cDNA libraries,Gene, 25:263-269.
Hanahan, D., 1983, Studies on transformation ofEscherichia coliwith plasmids,J. Mol. Biol., 166:557-580.
Hirai, K. et al., 2001, Polyvalent recombinant Marek's disease virus vaccine against poultry diseases,Curr. Top. Micro. and Immunol., 255:261-287.
Marshall, D.R. et al., 1993, Selection of Marek's disease virus recombinants expressing theEscherichia coligpt gene,Virol., 195:638-648.
McGeoch, D.J. et al., 1988, The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1,J. Gen. Virol., 69:1531-1574.
McGeoch, D.J. et al., 1999, Genbank accession No. D10879.
Morgan, R.W. et al., 1993, Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: Onset of protection and effect of maternal antibodies,Avian Diseases, 37:1032-1040.
Parcells, M.S. et al., 1994, Characterization of a Marek's disease virus mutant containing alacZinsertion in the US6 (gD) homologue gene,Virus Genes, 9(1):5-13.
Ross, L.J.N., 1998, Recombinant vaccines against Marek's disease,Avian Pathol., 27:S65-S73.
Sakaguchi, M. et al., 1994, Construction of recombinant Marek's disease virus type 1 (MDV1) expressing theEscherichia coli lacZgene as a possible live vaccine vector: The US 10 gene of MV1 as a stable insertion site,Vaccine, 12(10):953-957.
Sakaguchi, M. et al., 1998 Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1,Vaccine, 16(5):472-479.
Scharf, S.J., 1990, PCR Protocols: A Guide to Methods and Applications, In: Cloning with PCR, New York: Academic Press, Inc., pp. 84-91.
Sondermeijer, P.J.A. et al., 1993, Avian herpesvirus as a live viral vector for the expression of heterologous antigens,Vaccine, 11(3):349-358.
Sonoda, K. et al., 2000, Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies,J. Virol., 74(7):3217-3226.
VanZijl, M. et al., 1988, Regeneration of herpesviruses from molecularly cloned subgenomic fragments,J. of Virol., 62(6):2191-2195.
Wild, M.A. et al., 1996, A genomic map of infectious laryngotracheitis virus and the sequence and organization of genes present in the unique short and flanking regions,Virus Genes, 12(2):107-116.
Wild, M.A. et al., 1996, Genbank accession No. U28832.
Cochran Mark D.
Cook Stephanie M.
Wild Martha A.
Salimi Ali R.
Schering-Plough Veterinary Corporation
LandOfFree
Recombinant avian herpesvirus useful in vaccine production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant avian herpesvirus useful in vaccine production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant avian herpesvirus useful in vaccine production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3402322